Report Code: A14910 | Pages: NA | Mar 2023 | 729 Views | ||
Author(s) : NA | Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Efinaconazole Market
Request Now !Efinaconazole topical solution is used to treat fungal toenail infections (infections that may cause nail discoloration, splitting, or pain). Efinaconazole topical solution is in a class of medications called antifungals, which inhibit fungal lanosterol 14α-demethylase involved in biosysnthesis of ergosterol, a constituent of fungal cell membranes. This medication treats only fungal infections. It does not work for other types of infections, such as those caused by bacteria. Moreover, this medication is used to treat onychomycosis of toenails (tinea unguium and ringworm of the nail) caused by Trichophyton rubrum or T. mentagrophytes. It works by stopping growth of certain types of fungus.
Market Scope and Structure Analysis
Report Metric | Details |
 Market size available for years |  2020–2030 |
  Base year considered |  2020 |
 Forecast period |  2021–2030 |
 Forecast units |  Value (USD) |
 Segments covered |  Type, Mode of Administration, Application, End User, and Region |
Â
COVID-19 Scenario Analysis
The COVID-19 outbreak has transformed the national healthcare priorities and spending, however, it is considered to have short-term impact on the onychomycosis treatment market. Increase in number of COVID-19 patients around the world have led to increased focus on treatment of these patients on priority basis reduced patient visits to hospitals for diagnosis and treatment of onychomycosis or other nail and foot related fungal infections. Reduced visits indicate lesser treatment adoption, which has been affecting the market negatively. In addition, reduced visits to healthcare facilities to avoid cross contamination, which is another factor reducing sales. Â Moreover, onychomycosis generally is not given much importance as compared to other chronic diseases. Owing to reduced severity of the disease, the global efinaconazole market has experienced even lesser sales during the pandemic.
Top Impacting Factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis
Key Benefits of the Report
Questions Answered in the Efinaconazole Market Research ReportÂ
Report Tag: Antifungals, Fungal Infections, Toenail infections
Efinaconazole Market: Global Opportunity Analysis and Industry Forecast, 2021–2030 Report Highlights
Aspects | Details |
---|---|
By Type |
|
By Mode of Administration |
|
By Application |
|
By End User |
|
By Region |
|
Key Market Players | Kaken Pharmaceutical Co. Ltd., Procos S.p.A.,, Topharman CHEMVON BIOTECHNOLOGY (SHANGHAI) CO. LTD.,, Taizhou Volsen Chemical Co. Ltd.,, Valeant Pharmaceuticals International Inc.,, Zhejiang Ausun Pharmaceutical Co. Ltd.,, Tenova Pharmaceuticals Inc.,, Viwit Pharmaceuticals Limited,, RXN Chemicals Pvt. Ltd. |
Loading Table Of Content...
Start reading.
This Report and over 19,603+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers